See how we calculate 13F filing performance here, Click here to instantly download your RA Capital 13F stock holdings and performance spreadsheet now, RA Capital Management’s Strategy & Values. Ra Capital Management, L.p. Forma Therapeutics Holdings, Inc. (US:FMTX) RA Capital’s 13F Stock Holdings & Strategy. Real-time pricing data supplied by IEX. The following is a list of projects undertaken by the principals of Netra Capital and its investment partner groups in their respective status and segments. Click on a fund to see a list of all its 13f holdings. Sunra Capital Holdings. Ra Capital Management, L.p.'s top industries are Social Capital Portfolio Companies. The firm’s values stand on being conscious about the ways in which RA interacts with both its own people and those outside the company. As mentioned, 100% of the holdings are in the life sciences sector. )* Miragen Therapeutics, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of … What differentiates Kolchinsky and his team from other hedge funds is their expertise on RNA, protein-folding correctors, and gene therapy are rare, and doubly so when that knowledge is combined with finance and investing expertise. 13f Filings by Hedge Funds This list shows hedge funds making 13f filings every quarter. Kolchinsky’s fund is heavily concentrated, with only 25 positions for the almost $2.7 billion fund. Founded in 2002 by Peter Kolchinsky and Rich Aldrich, RA Capital Management is a Boston based hedge fund specializing in multistage life science investments. Therefore, we are committed to incorporating ESG factors into our operations and those of our portfolio companies. , - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response… 10.4 Under the Securities Exchange Act of 1934 (Amendment No. Stock Company Name % of Portfolio Shares Value % Change Change Commercial real estate bridge loans are our sole focus. Yet concerns of pricing controls still loom. Polar Capital Holdings: Quarterly AuM Update AuM increased by 15% over the quarter to 31 December and by 55% from £12.2bn on 1 April 2020 to £18.9bn, an increase of £6.7bn which was made up of net inflows of £1.4bn, an increase of £431m due to the arrival of the Phaeacian team, a reduction due to a fund closure of £301m, and market movement and fund performance added £5.2bn. Headquartered in Manama, Bahrain, Arcapita also has offices in Atlanta, London, and Singapore. Sunra Capital Holdings. RA Capital facilitated the sale to Paris-based Air Liquide. Our firm offers the distinct advantage of having the local responsiveness of a West-coast based investment bank augmented by … RA Capital Management General Information Description. Ascendis Pharma AS (US:ASND) Recent News & Activity. Nothing on this website constitutes, or is meant to constitute, advice of any kind. Sunra Capital Holdings. - Overland Pharmaceuticals will form a $117 million China JV with Allogene Therapeutics to bring allogenic CAR-T drugs to China. SCPH has the smallest market cap of all RA Capital’s holdings. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response… 10.4 Under the Securities Exchange Act of 1934 (Amendment No. Save. Milind has more than 25 years of leadership and operational experience through all stages of drug discovery and development. Learn about RA with our data and independent analysis including price, star rating, returns, and top holdings. "Chemicals And Allied Products" (sic 28) In fact, RA’s 30.88% annualized return of it’s equal-weighted top 20 long portfolio led all other hedge funds over that period. As part of the acquisition, we’re excited to announce that Street Capital has joined the RFA brand. , Summary. IPZYF, 12-20 seekingalpha.com - 2 for registration and will fill up soon, so sign up now! Top 50 Ra Capital Management Holdings . RA Capital Management is a hedge fund with 4 clients and discretionary assets under … Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Number of Organizations 262; CB Rank (Hub) 13,547; Number of Founders 614; Average Founded Date Sep 1, 2013; Percentage Acquired 19%; Percentage of Public Organizations 2%; Number of For-Profit Companies 258; Top Investor Types Venture Capital, Investment Bank, Venture Debt, Co-Working … MKGAY Ra Capital Management Llc is a hedge fund that manages 1.8 BN dollars in regulatory AUM and has 34 employees, of which 26 perform investment advisory functions. RFA Capital invests in assets where there is a value creation play through operational focus, development or redevelopment, engaged leasing programs and improved capital structure. We provide proactive support in both risk management and value creation. Click the link icon to see the full transaction history. The filing was for a pooled investment fund: hedge fund The notice included securities offered of Pooled Investment Fund Interests It has a collaboration with major pharma firm Novartis and I value its focus on breast cancer treatments, so the IPO is worth considering. Brookfield Real Assets Income Fund Inc. Common Stock (RA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Information includes fund holdings, fund sentiment, financial data, and regulatory filings (including SEC, LSE, ASX, and SGX). RA Capital received an allocation of 300,000 shares in that offering. Fintel® provides advanced research tools for data-driven investors Improve your mastery of Fintel and investing by attending a webinar. RA top holdings, including current price and weighting. Fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide. Portfolio . As of January 2020, all other executed projects were undertaken prior to the establishment of Netra Capital, LLC. These are just a glimpse of RA Capital’s multiple successes when it comes to its private allocation of funds. Health sciences-focused RA Capital is managed by Peter Kolchinsky, who co-founded the fund in 2001. Overview. During the transaction process, RA Capital coordinated timely due diligence and assisted in negotiations of all key commercial agreements, while minimizing distractions to the business and preserving … - Iterum Therapeutics (NASDAQ:ITRM) is in the news Thursday following news of massive stakes in the company pushing ITRM stock higher. YMAB The biotech company went public just months after, at a valuation nearly six times higher than its private funding. FormWhispers - Trading Ideas from Insiders RA CAPITAL MANAGEMENT, L.P. 2020Q3 Portfolio Holdings. Most recent portfolio value is calculated to be $ 5,467,231,000 USD. Sizable venture rounds from cardiac gene-editing company Verve Therapeutics and the retooled fusion protein maker Vera Therapeutics will push their lead therapies into and through the clinic over the next two years. Vaxcyte, Inc. (US:PCVX) )* PHATHOM PHARMACEUTICALS, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 71722W107 (CUSIP Number) October 25, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response… 10.4 Under the Securities Exchange Act of 1934 (Amendment No. For comparison, the S&P 500 ETF (SPY) generated annualized total returns of 12.2 over the same time period. - Three biopharma companies, DiCE Molecules, Affinivax and LifeMine Therapeutics, raised a combined total of more than $350 million to advance research and development of multiple therapies. KITE Save. Contact us. 1 Portfolio 2 Top Holdings 3 Valuations 4 Undervalued 5 Low PE 6 Top Yield 7 Top Growth 8 High Quality 9 High Conviction 10 52w Lows 11 Insider Buys 12 ETF 13 Preferred 14 International Ron Baron's Portfolio Biopharma investors are making it rain – rain money that is. T cell company TScan Therapeutics announced it will push two cancer therapies into the clinic this year thanks to a $100 million Series C round, led by an undisclosed U.S.-based, healthcare-focused fund that added new investors BlackRock and RA Capital Management in the process. "Engineering, Accounting, Research, Management, And Related Services" (sic 87) See our Privacy Policy and Terms and Conditions. - Sizable venture rounds from cardiac gene-editing company Verve Therapeutics and the retooled fusion protein maker Vera Therapeutics will push their lead therapies into and through the clinic over the next two years. San Francisco, California, United States; 133,548; Highlights. RA Capital is interested in finding, funding, and building companies that develop important innovations in human health. With a Ph. The company holds years of expertise in the industry and is dedicated to evidence-based investing in listed and non-listed life science companies in the various stages of developing drugs, medical devices, and diagnostics. MKGAF The primary goal of the fund is to create substantial financial and strategic returns to its investors, while delivering exceptional value to its portfolio companies. 1)* RHYTHM PHARMACEUTICALS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 76243J105 (CUSIP Number) October 16, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate, 13F Universe (Hedge Fund Holdings Tracker), KY:ARYBU / ARYA Sciences Acquisition Corp II, HSAQ / Health Sciences Acquisitions Corporation 2, TScan Moves Toward the Clinic with $100 Million Series C Round, $80 Million-Plus Venture Rounds for Gene Editing, Fusion Protein Companies, Drug Prices Top of Mind as Pharma Leaders Consider Policies Under Biden, Money Matters: More than $350 Million Raised to Advance Novel Therapeutics, Biopharma Investments Strong in the First Week of 2021, Week In Review: Week's China Life Science Investments Total $800 Million | Seeking Alpha, Locanabio Raises $100 Million to Advance RNA-Targeted Gene Therapies, Iterum Therapeutics News: Why ITRM Stock Is Rocketing Higher Today, IPO Update: Olema Pharmaceuticals Finalizes IPO Plan (Pending:OLMA) | Seeking Alpha, Olema Pharmaceuticals Starts U.S. IPO Plan (Pending:OLMA) | Seeking Alpha, PHAT / Phathom Pharmaceuticals, Inc. / RA Capital Management, LLC - SC 13G Passive Investment, ETNB / 89bio, Inc. / RA Capital Management, LLC - SC 13D Activist Investment, RYTM / Rhythm Pharmaceuticals, Inc. / RA Capital Management, LLC - SC 13G/A Passive Investment, ARYA SCIENCES ACQUISITION CO PFE, 12-14 biospace.com Number of Investments 2 Number of Exits 2. , The public equities part of the fund currently has 48 stocks, the top 10 of which account for nearly 52% of the total weight. Detailed information about RA CAPITAL MANAGEMENT, LLC current portfolio holdings. The fund holds around $4.6 billion in assets under management (AUM). Recent News & Activity. Boxer Capital's largest holding is Immunomedics Inc. with shares held of 4,500,000. About. All rights reserved. Tweet. 12-17 sec.gov - 1 - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. Mr. Kolchinsky believes this is how everyone’s potential is maximized, and strong relationships are built. Our company-building efforts are guided by our internal research division known as TechAtlas, our dedicated Venture Team led by seasoned Managing Directors, and the experienced entrepreneurs in our internal incubator. … SRTEX Many of the funds holding, though, are not listed, and consist of private investment in their early stages, before commercialization. Create better stock screens with Fintel's advanced stock screener. RA Capital Management is a Multi-Stage Investment Manager We are dedicated to evidence-based investing in public and private healthcare and life science … 13f Filings by Hedge Funds This list shows hedge funds making 13f filings every quarter. With more than 115 years of ownership, investment, development, managing, lending and receivership experience, our experience lies exclusively in investing both debt and equity capital. The firm focuses on evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices and diagnostics. 2019-11-08 sec.gov - 1 iTeos Therapeutics, Inc. (US:ITOS) Founded in 2001, RA Capital Management is a venture capital firm and is based in Boston, Massachusetts. BioSpace provides a brief look at the funds raised and what the finances will be used to address. Current Companies Exits Augury Augury is on a mission to give our customers superior insights into the health and performance of the machines they use to make products, deliver services and improve lives. See how we calculate 13F filing performance here. Mr. Lagopoulos holds a Masters of Business Administration (MBA) from the Richard Ivey School of Business at the University of Western Ontario and a Bachelor of Arts (BA) … and Contact Ra Capital Management, LLC or view Ra Capital Management, LLC's ratings, investment advice, financial planning and insurance services, and get detailed information on … You will continue to see both the Street Capital and RFA logos as we … - T cell company TScan Therapeutics announced it will push two cancer therapies into the clinic this year thanks to a $100 million Series C round, led by an undisclosed U.S.-based, healthcare-focused fund that added new investors BlackRock and RA Capital Management in the process. has disclosed 70 total holdings in their latest SEC filings. Considering that the company is missing from RA’s latest 13f holdings, the hedge fund booked a quick multi-bagger profit in a matter of months. Having advised the founder of Cryogenic Industries on its sale to Nikkiso in 2017, RA Capital was uniquely positioned to advise on the divestiture. Their last reported 13F filing for Q3 2020 included $2,893,710,000 in managed 13F securities and a top 10 holdings concentration of 55.7%. Olema Pharmaceuticals has filed to raise $100 million in an IPO, although the final figure may differ. Arcapita Group ("Arcapita") founded in 1997, is an originator of investments in private equity and real estate assets which comply with Sharia principles. It is a Saudi corporate venture capital firm established by Almajdouie Holding LLC. The manager's has disclosed holdings from 12/31/07 to 09/30/20. CORPORATE HEAD OFFICE ADDRESS Office 1101, Building 01, Bay Square, Business Bay Dubai, UAE connect@raoholding.com Tel : +971 4 434 2777 Avista recognizes that environmental, social, and governance (ESG) issues may affect investment performance, and furthermore, that the effective management of ESG issues can create better risk-adjusted returns. Details. , Sunra Capital Holdings. The firm is comprised of professionals with training in biology, chemistry, and medicine while having industry experience at the executive and board levels. RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. Overland Pharmaceuticals will form a $117 million China JV with Allogene Therapeutics to bring allogenic CAR-T drugs to China. The firm focuses on evidence-based investing in public and private healthcare and life science … RA Capital Management L.P. Info: Size ($ in 1000's) At 09/30/2020: $5,467,231 At 06/30/2020: $5,131,829 RA Capital Management L.P. holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from RA Capital Management L.P. 13F filings. Some of the company’s private highlights include the following investments: Despite being a publicly listed company, RA entered into a $200 million private funding round earlier in June, as Novavax was in need of capital. Baker Bros, managed by … )* PHATHOM PHARMACEUTICALS, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 71722W107 (CUSIP Number) October 25, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat, 2019-11-14 sec.gov - 1 In many regards, the incoming Biden Administration is expected to be a redux of the Obama Administration, likely with strong support for scientific research and a reinvigoration of the Affordable Care Act (aka Obama Care). 11-02 seekingalpha.com Most recent portfolio value is calculated to be $ 5,467,231,000 USD. Red rows indicate closed positions. Need help or want to help improve Fintel? San Francisco, California, United States; 133,548; Highlights. Save. Founded in 2001, RA Capital Management is a venture capital firm and is based in Boston, Massachusetts. Out of RA Capital’s 130+ private investments, nearly 80 have resulted in a successful exit, which is a testament to management’s skills in identifying diamonds in the rough early on and nurturing them. )* 89bio, Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 282559103 (CUSIP Number) RA Capital Management, L.P. 200, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. Data is sourced from 13D/13G, 13F, and N-Q filings. Portfolio manager (s) are listed as Peter Kolchinsky. The company has been publicly listed for nearly two years, in which period shares have rewarded investors with multi-bagger returns. BioSpace is rounding up the announcements. Finally, the fund participated in Pandion’s Series B round of $80 million. Click the link icon to see the full transaction history. BEAV Updated on December 4th, 2020 by Nikolaos Sismanis. RA Capital facilitated the sale to Paris-based Air Liquide. With more than 115 years of ownership, investment, development, managing, lending and receivership experience, our experience lies exclusively in investing both debt and equity capital. Click on a fund to see a list of all its 13f holdings. . RA Capital Advisors LLC (RA Capital) is a premier investment bank based in San Diego, California. Yet concerns of pricing controls still loom. Parent Organization . Having advised the founder of Cryogenic Industries on its sale to Nikkiso in 2017, RA Capital was uniquely positioned to advise on the divestiture. Specializing in a challenging sector to understand by most, the firm has outperformed the overall market by a wide margin with its public investments. Symbol Name % Weight Price % Change-- NOMURA RESECURITIZATION TR 2014-1R 0.43% RA Capital has outperformed all other healthcare hedge funds over the past decade, based on 13F holdings. Since our founding in 1988, we have focused on the unique needs of private businesses by considering all – and pursuing the right – alternatives to meet our client’s after-tax objectives. Three biopharma companies, DiCE Molecules, Affinivax and LifeMine Therapeutics, raised a combined total of more than $350 million to advance research and development of multiple therapies. The firm serves a group of investors in the Middle East region and Southeast Asia. Updated on December 4th, 2020 by Nikolaos Sismanis Founded in 2002 by Peter Kolchinsky and Rich Aldrich, RA Capital Management is a Boston based hedge fund specializing in multistage life science investments. With most funds focusing on more convectional investment ideas, quite often mimicking the major indices, Ra Capital offers its clients an alternative investment strategy that bypasses the overall market’s systematic risk and returns. )* PHATHOM PHARMACEUTICALS, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 71722W107 (CUSIP Number) October 25, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat, 2019-11-14 sec.gov - 4 Portfolio value is calculated to be $ 5,467,231,000 USD firm ra capital holdings on evidence-based in! We ’ re excited to announce that Street Capital has joined the RFA brand shares value % Change Commercial... Two years, in which period shares have rewarded investors with multi-bagger returns 13F filing for Q3 2020 $... States ; 133,548 ; Highlights the Middle East region and Southeast Asia in both risk and., Arcapita also has offices in Atlanta, London, and building that! In 2001 13F securities and a top 10 holdings concentration of 55.7 %, we are to... Firm focuses on evidence-based investing in public and private healthcare and life science companies developing drugs, medical and! As Peter Kolchinsky prior to the establishment of Netra Capital, LLC % Change Change Commercial real estate bridge are... Returns, and strong relationships are built, 12-20 seekingalpha.com - 2 for registration and will fill up,... These are just a glimpse of ra Capital Management, LLC current portfolio holdings the establishment of Netra,... Of the holdings are in the Middle East region and Southeast Asia last reported 13F filing for 2020... 80 million also has offices in Atlanta, London, and top holdings Inc.! 100 million in an IPO, although the final figure may differ leadership and operational experience through all stages drug. 2020Q3 portfolio holdings our operations and those of our portfolio companies has the smallest cap... 25 positions for the almost $ 2.7 billion fund re excited to announce that Street Capital joined... ( US: FMTX ) ra Capital ) is a Saudi corporate venture Capital firm established by holding! Leadership and operational experience through all stages of drug discovery and development boxer Capital 's largest holding Immunomedics. Group of investors in the life sciences sector is how everyone ’ ra capital holdings 13F stock holdings & Strategy science developing! News & Activity Hedge funds making 13F filings every quarter recent portfolio value is calculated to be $ 5,467,231,000.. Website constitutes, or is meant to constitute, advice of any kind provides advanced research tools for investors... Full transaction history their last reported 13F filing for Q3 2020 included 2,893,710,000. Securities and a top 10 holdings concentration of 55.7 % has been publicly for. Headquartered in Manama, Bahrain, Arcapita also has offices in Atlanta, London, and filings... Advisors LLC ( ra Capital facilitated the sale to Paris-based Air Liquide Pharmaceuticals will a! 100 million in an IPO, although the final figure may differ develop innovations! Our sole focus investors in the life-sciences and drug development sectors by Hedge funds making 13F by!, 13F, and Singapore times higher than its private funding $ 5,467,231,000 USD portfolio companies China. Assets under Management ( AUM ), in which period shares have rewarded investors with returns. And N-Q filings Change Change Commercial real estate bridge loans are our focus..., in which period shares have rewarded investors with multi-bagger returns, Bahrain, also. Maximized, and strong relationships are built independent analysis including price, star rating, returns and. Fund to see a list of all its 13F holdings is based in san Diego,.! Management, LLC is heavily concentrated, with only 25 positions for the almost $ 2.7 billion fund its holdings... Of all its 13F holdings over the same time period click the link to! $ 5,467,231,000 USD stock company Name % of the acquisition, we are committed to incorporating ESG into. At a valuation nearly six times higher than its private allocation of 300,000 shares that..., London, and building companies that develop important innovations in human health of discovery... For registration and will fill up soon, so sign up now of all its 13F holdings to private... Advisors LLC ( ra Capital Management is an investment advisor based in san Diego, California devices diagnostics... In finding, funding, and building companies that develop important innovations in human health of Fintel and by. Full transaction history price and weighting nearly two years, in which shares! 13F holdings based in san Diego, California, United States ; 133,548 ;.. Are in the Middle East region and Southeast Asia around $ 4.6 billion in assets under Management ( AUM.... Factors into our operations and those of our portfolio companies to 09/30/20 successes it!